 Best Practices in Adult ADHD: Epidemiology, Impairments, and Differential Diagnosis PsychCast™ (70 Minutes)
Faculty: Lenard A. Adler, MD, Thomas J. Spencer, MD, Mark A. Stein, PhD, and Jeffrey H. Newcorn, MD
This CME Expert Review PsychCast™ is jointly sponsored by the Mount Sinai School of Medicine and MBL Communications.
Release Date: September 2008
Termination Date: September 30, 2010
Estimated time to complete this activity: 1 hour
Medium: The content is delivered by PsychCast™ with a PDF or web-based Posttest
Acknowledgment of Commercial Support: Funding for this activity has been provided by an educational grant from Shire Pharmaceuticals Inc.
CME Course Director: This activity has been peer-reviewed and approved by Eric Hollander, MD, Chair and Professor of Psychiatry at Mount Sinai School of Medicine. Review Date: July 22, 2008
Faculty Affiliation
Dr. Adler is associate professor of psychiatry and child and adolescent psychiatry, and director of the Adult ADHD Program, both at the New York University Langone School of Medicine.
Dr. Spencer is associate professor of psychiatry at Harvard Medical School and associate director of the Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital in Boston.
Dr. Stein is professor in the Department of Psychiatry a the University of Illinois in Chicago and director of the Adult ADHD Clinic.
Dr. Newcorn is associate professor in the Department of Psychiatry at the Mount Sinai School of Medicine in New York City.
Faculty Disclosure Policy Statement
It is the policy of the Mount Sinai School of Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.
Faculty Disclosure
Dr. Adler is a consultant to and on the advisory boards of Abbott, Cephalon, Cortex, Eli Lilly, Novartis, Ortho-McNeil, Janssen, Johnson and Johnson, Merck, New River, Organon, Pfizer, sanofi-aventis, and Shire; is on the speaker’s bureaus of Eli Lilly and Shire; and receives grant/research support from Abbott, Bristol-Myers Squibb, Cephalon, Cortex, Eli Lilly, Janssen, Johnson and Johnson, Merck, National Institute of Drug Abuse, New River, Novartis, Ortho-McNeil, Pfizer, and Shire.
Dr. Newcorn is a consultant to Abbott, Biobehavioral Diagnostics, Eli Lilly, Lupin, Novartis, Ortho-McNeil, Psychogenics, sanofi-aventis, and Shire; and receives research support from Eli Lilly and Ortho-McNeil.
Dr. Spencer is a speaker for Eli Lilly, GlaxoSmithKline, Janssen, Novartis, Ortho-McNeil, and Shire; is on the advisory boards of Cephalon, Eli Lilly, GlaxoSmithKline, Janssen, Novartis, Ortho-McNeil, Pfizer, and Shire; and receives research support from Cephalon, Eli Lilly, GlaxoSmithKline, Janssen, National Institute of Mental Health, Novartis, Ortho-McNeil, Pfizer, and Shire.
Dr. Stein is a consultant/advisor to Abbott, Novartis, and Pfizer; is a speaker for Novartis and Ortho-McNeil; and receives research support from Eli Lilly, National Institute of Mental Health, Organon, Ortho-McNeil, and Pfizer.
Dr. Hollander reports no affiliation with or financial interest in any organization that may pose a conflict of interest.
Learning Objectives
- Review the epidemiology of attention-deficit/hyperactivity disorder (ADHD), including prevalence, persistence, and co-morbid tendencies.
- Explain the common impairments associated with adult ADHD and how to incorporate assessment of impairment levels into the diagnostic process.
- Discuss the differential diagnosis and psychiatric co-morbidities that require consideration in the assessment of adult ADHD.
Target Audience: This activity is designed to meet the educational needs of primary care physicians and psychiatrists.
Accreditation Statement: This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Mount Sinai School of Medicine and MBL Communications, Inc. The Mount Sinai School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: The Mount Sinai School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclaimer: These are the opinions of the authors not of the sponsors or supporters. For more information, contact MBL Communications at cme@mblcommunications.com.
Minimum Hardware/Software Requirements
Macintosh: PowerPC processor, Mac OS 8.6, 9.0.4, 9.1, or Mac OS X, 64MB of RAM, 24MB of available hard-disk space, and Safari 1.x or 2.x.
Windows PC: Intel Pentium processor, Microsoft Windows 95 OSR 2.0, Windows 98 and 98 SE, Windows Millennium Edition, Windows NT 4.0 with Service Pack 5, Windows 2000, or Windows XP, 64MB of RAM, 24MB of available hard-disk space, and Internet Explorer 6.x and newer or Firefox 1.x and newer.
This CME Activity and Posttest information file is a PDF (Portable Document Format) document. To view this file, you will need Adobe Acrobat Reader, which is available free at www.adobe.com. Follow the instructions on that page to download and install the software.
Best Practices in Adult ADHD: Epidemiology, Impairments, and Differential Diagnosis PsychCast™ (70 Minutes)
Faculty: Lenard A. Adler, MD, Thomas J. Spencer, MD, Mark A. Stein, PhD, and Jeffrey H. Newcorn, MD
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is commonly thought to be a pediatric disorder whose symptoms attenuate or disappear in adulthood. In fact, approximately 4% of adults in the United States have ADHD, and many of these adults are unaware that they have the disorder. Because symptoms of ADHD manifest differently in adults and children, physicians who are familiar with childhood ADHD have difficulty identifying the disorder in adults. Adults with ADHD themselves may be poor informants about their symptoms and impairments. A high prevalence of mood and other co-morbid disorders in adults with ADHD can also complicate diagnosis and treatment. Adults with ADHD experience high rates of anxiety disorders, mood disorders, substance use disorders, and impulse disorders. Adult ADHD is related to impairments in executive functioning and adaptive functioning; these patients have unique deficits related to their roles as parents, caregivers, and employees. Physicians should use impairments to guide treatment design. Early identification and treatment of ADHD can alter the developmental course of co-morbid disorders. Unfortunately, metrics for impairment in adult ADHD are still in their infancy.
This Expert Roundtable PsychCast represents part 1 of a 3-part PsychCast series on adult ADHD led by Lenard A. Adler, MD. In this activity, Thomas J. Spencer, MD, reviews the epidemiology of adult ADHD in the US and around the world; Mark A. Stein, PhD, reviews data on the impairments resulting from adult ADHD; and Jeffrey H. Newcorn, MD, discusses the differential diagnosis of adult ADHD and common co-morbidities.
To receive credit for this activity: Listen to the PsychCast™, reflect on the material presented, and complete the online CME Posttest/Evaluation here or to submit the CME Posttest/Evaluation by mail or fax, download a PDF here. To obtain credit, you should score 70% or better. The estimated time to complete the PsychCast™ and the posttest and evaluation is 1 hour. Successful completion of the posttest and evaluation will allow you to claim credit and print a certificate.
Early submission of this posttest is encouraged: please submit by September 1, 2010 to be eligible for credit. If you have any questions, please e-mail cme@mblcommunications.com.
Read the extended CME supplement related to this PsychCast™ activity here
Supported by Shire Pharmaceuticals Inc. |
Subscribe |
Download |
|
|
|
|
